Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe

CMS expert Daubert sees “great improvement” in proposed rule

September 10, 2020 By Tom Salemi

DTW w MD

DeviceTalks Weekly, powered by MassDevice

In this week’s DeviceTalks Weekly Podcast, we talk with Gail Daubert, founding partner of 4Front Strategic Partners, a new reimbursement strategy firm.

Daubert, a trained ER nurse and former partner at Reed Smith LLP, co-founded 4Front following some personal tragedy in her life.

The interview with Daubert includes the below exchange regarding CMS’s proposed rule change that would open up reimbursement for Innovative breakthrough technologies.

To hear her story, listen to this episode of the DeviceTalks Weekly Podcast.

You’ll also hear:

  • Chris Newmarker, executive editor of life sciences at MassDevice, reports on the five biggest Medtech newsmakers, including Medtronic, IBM, Elon Musk and CMS.
  • Karen Long, managing director of KCK, share the firm’s strong interest in medtech investing.

DeviceTalks Weekly: Please explain the impact of the new rule.
Gail Daubert: If it’s adopted as proposed (this proposed rule) will ensure that completely new breakthrough technology will be covered by Medicare. There are three components to reimbursement or payment: coding, coverage, and payment.
Obtaining coverage is perhaps the most challenging component – it generally requires multiple peer-reviewed publications and long-term follow-up, especially for implanted devices. In a separate proposed rule, CMS discussed additional opportunities to obtain payment for breakthrough devices. There is only component missing — CMS needs to set up a streamlined process to establish a code that describes the new technology procedure. And I’m sure many startup companies and even well-established companies will most likely be commenting on that process. There needs to be an easier way to obtain a billing code, a billing code is needed to report and get paid for the procedure.

DTW: If I’m CEO of a company developing a new technology, it doesn’t mean that I’m automatically in line for reimbursement from Medicare, but what does it mean? How does this make my life easier?
Gail Daubert: If it’s adopted, once you obtain a billing code, then you will have an assurance that as the claim is processed, the provider will be more likely to embrace the adoption of the new technology, because they know that…there’s going to still be this delay, unless CMS modifies it to set up a billing code in conjunction with the expanded coverage. Otherwise, you know, Medicare is proposing to provide coverage on the same date as FDA marketing authorization is received, and that’s going to be problematic because the shortest timeframe to obtain any type of billing code is about four months, five months. So they’re going to, Medicare will start the clock ticking on FDA approval or marketing authorization, and there’ll be sitting there. They’ll know, you know, they will be able to tell a good story that once they have a code, it will be paid — covered —  and the hospital should get reimbursement. But I think there’s still going to be a bit of a delay and start up. Companies are still going to have to figure out how to get that code or should begin advocating for a streamline coding process today.

DTW: So per this proposed rule, if my technology gets FDA approval, that automatically puts me on the clock to get CMS reimbursement.
Gail Daubert: It puts you on the clock to get Medicare coverage and coverage means that the procedure is reasonable, necessary, and patients should have access to it. The problem is that the healthcare providers communicate to insurers and to Medicare by reporting billing codes on an electronic claim form. In most instances, if that CPT code or HCPCS code that describes that procedure it’s already loaded into the payer’s system. So to speak, it will generally have a payment rate associated with it. And then will generally be flagged, but it’s covered or non-covered. So it may, if it’s non-covered, it gets kicked out and they, the payer sends their response back to the provider. It’s non-covered for reasons such as, ‘We don’t view this as reasonable and necessary or safe and effective or experimental and investigational,’ and those are all legitimate concerns. So medical device manufacturers are going to need a code, especially a code to put on that claim in order to have the process runs smoothly. I think this is a great improvement and the process. So I applaud what CMS has done. I think there’s still that one missing piece….”

To hear the missing piece, listen to this week’s DeviceTalks Weekly podcast.

DeviceTalks by MassDevice · Raising capital during Covid with Karen Long; Gail Daubert on CMS changes, Are linked pigs scary?

Related Articles Read More >

A photo of FDA Associate Director for TAP April Marrone.
How device innovators can make the most of FDA’s TAP accelerator
A photo of Kolaleh Eskandanian.
Cleared for every child, covered for none, priced for the parents who can pay
A photo of FDA Commissioner Marty Makary
FDA, CMS unveil accelerated Medicare coverage pathway for breakthrough devices
A photo of Aclarion CEO Brent Ness.
The blueprint for commercializing breakthrough healthtech
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe